COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.
Also called NCT01752127
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 600 participants
- Registry
-
NCT01752127
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01752127. Randomized; single masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2013-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease
- Acronym
- COPERES
- Condition
- Angioplasty, Balloon, Coronary
- Intervention (Procedure)
- percutaneous coronary intervention using drug eluting stent
- Lead sponsor
- Chonbuk National University Hospital
Record details
- Record id
cardio:ct-nct01752127- Content hash
9ffd9007455b9735c6fc63a7405874a0830dd80e84622f79f7473bac3f6ef04e